FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Lawmakers Ask FDA to Fix Orange Book Loopholes

Senator Elizabeth Warren (D-MA) and Rep. Pramila Jayapal (D-WA) urge FDA commissioner Robert Califf to restrict patents that are listed in the Orange ...

latest-news-card-1
Medical Devices

ICU Medical Infusion Pump Cleared

FDA clears an ICU Medical 510(k) for the Plum Duo infusion pump with LifeShield infusion safety software.

latest-news-card-1
Federal Register

Info Collection on FDA Surveys

Federal Register notice: FDA sends to OMB an information collection extension entitled Customer/Partner Service Satisfaction Surveys.

latest-news-card-1
Human Drugs

FDA OKs 15 Vyvanse Generics

FDA approves 15 ANDAs representing the first generics of Takedas Vyvanse (lisdexamfetamine dimesylate) capsules and chewable tablets, indicated for at...

latest-news-card-1
Human Drugs

Janssen Files sBLA for Expanded Rybrevant

Janssen Pharmaceutical files a supplemental BLA seeking an expanded approval for Rybrevant (amivantamab-vmjw) combination use with chemotherapy (carb...

Medical Devices

Boston Scientific Positive Ablation Study

Boston Scientific reports positive 12-month results from its pivotal ADVENT clinical trial of the FaraPulse Pulsed Field Ablation System, a nonthermal...

latest-news-card-1
Human Drugs

Data Integrity Issues at Synapse Labs: Petition

A Flag Pharma citizen petition asks FDA to revisit the therapeutic equivalence ratings of generic drug products that relied on bioequivalence studies ...

latest-news-card-1
Medical Devices

FDA Clears BioProtect Balloon Implant

FDA clears a BioProtect 510(k) for its BioProtect Balloon Implant System, a next-generation spacer designed to provide protection to the rectum during...

latest-news-card-1
Biologics

AbbVie sBLA for Skyrizi in Crohns

AbbVie submits a supplemental BLA for Skyrizi (risankizumab) 1,200 mg intravenous (induction dose) and 180 mg and 360 mg subcutaneous (maintenance dos...

latest-news-card-1
Human Drugs

Novocure Phase 3 Study Misses Primary Endpoint

Novocure says its Phase 3 ENGOT-ov50/GOG-3029/INNOVATE-3 clinical trial of Tumor Treating Fields together with paclitaxel in patients with platinum-re...